Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 7Unknown 3Terminated 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Neoplasms 3Glioblastoma 3Neuroblastoma 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Tumor 2Thymoma 1Retinoblastoma 1Resectable Pancreatic Cancer 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Objective Response Rate 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Advanced Refractory Solid Tumors 1

Interventions

Temozolomide 44Radiotherapy 16Bevacizumab 9Surgical Procedures, Operative 5Carmustine 5pembrolizumab 4Lomustine 4Drug Therapy 4Sunitinib 3Standard of Care 3Radiation 3Procarbazine 3Irinotecan 3Granulocyte-Macrophage Colony-Stimulating Factor 3Chlorotoxin 3Carboplatin 3Blood Specimen Collection 3tislelizumab 2fludarabine 2camrelizumab 2Radiosurgery 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Hyperbaric Oxygenation 2Ethanol 2Cyclophosphamide 2Chemotherapy, Adjuvant 2CT-322 2Bortezomib 2Aminolevulinic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Glioblastoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT05131711 2021-11-23

CSREIG

Beijing Tiantan Hospital

Phase 1/2 Unknown
60 enrolled
CNS

Glioblastoma

NCT03392545 2019-07-11

InSituVac1

Beijing Tiantan Hospital

Phase 1 Unknown
30 enrolled
CNS

Glioblastoma, Glioma

NCT02663440 2016-01-26

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Zhejiang Cancer Hospital

Phase 2 Unknown
41 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡